Co-targeting 26S proteasome and mGluR1 using bortezomib and riluzole suppresses the progression of androgen-independent prostate cancer
- DOI
- 10.1007/s12032-026-03464-7
- Published
- 2026-11-04
- Container
- Medical Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12032-026-03464-7,
title = {Co-targeting 26S proteasome and mGluR1 using bortezomib and riluzole suppresses the progression of androgen-independent prostate cancer},
author = {Ahmed S. Alhallaq and Nadeen S. Sultan and Heba Alwasify and Yasser M. Elsherbini and Mohamed E. Abdraboh},
year = {2026},
journal = {Medical Oncology},
doi = {10.1007/s12032-026-03464-7},
url = {https://doi.org/10.1007/s12032-026-03464-7}
}RIS
TY - JOUR TI - Co-targeting 26S proteasome and mGluR1 using bortezomib and riluzole suppresses the progression of androgen-independent prostate cancer AU - Ahmed S. Alhallaq AU - Nadeen S. Sultan AU - Heba Alwasify AU - Yasser M. Elsherbini AU - Mohamed E. Abdraboh PY - 2026 JO - Medical Oncology DO - 10.1007/s12032-026-03464-7 UR - https://doi.org/10.1007/s12032-026-03464-7 ER -
APA
Alhallaq, A. S., Sultan, N. S., Alwasify, H., Elsherbini, Y. M., & Abdraboh, M. E. (2026). Co-targeting 26S proteasome and mGluR1 using bortezomib and riluzole suppresses the progression of androgen-independent prostate cancer. Medical Oncology. https://doi.org/10.1007/s12032-026-03464-7
Source records
- crossref · retrieved 2026-11-09T09:56:00.011Z